Phreesia (NYSE:PHR) Insider Yvonne Hui Sells 1,371 Shares of Stock

Phreesia, Inc. (NYSE:PHR) insider Yvonne Hui sold 1,371 shares of the company’s stock in a transaction on Monday, July 6th. The shares were sold at an average price of $10.84, for a total value of $14,861.64. Following the transaction, the insider directly owned 23,908 shares in the company, valued at $259,162.72. The trade was a 5.42% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Yvonne Hui also recently made the following trade(s):

• On Friday, April 17th, Yvonne Hui sold 1,327 shares of Phreesia stock. The shares were sold at an average price of $9.28, for a total value of $12,314.56.
• On Thursday, April 16th, Yvonne Hui sold 10,063 shares of Phreesia stock. The shares were sold at an average price of $9.08, for a total transaction of $91,372.04.

Phreesia Stock Down 1.4%

PHR stock opened at $10.95 on Wednesday. The company has a 50 day moving average of $9.56 and a two-hundred day moving average of $11.67. The company has a market cap of $676.51 million, a price-to-earnings ratio of 72.97 and a beta of 0.87. Phreesia, Inc. has a 12-month low of $7.77 and a 12-month high of $32.76. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.41.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.03. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The business had revenue of $130.94 million during the quarter, compared to analyst estimates of $130.08 million. During the same period last year, the company earned ($0.07) earnings per share. Phreesia’s quarterly revenue was up 12.9% compared to the same quarter last year. On average, equities analysts anticipate that Phreesia, Inc. will post 0.39 earnings per share for the current fiscal year.

Phreesia News Roundup

Here are the key news stories impacting Phreesia this week:

• Negative Sentiment: Several firms, including Faruqi & Faruqi, Rosen, Pomerantz, Holzer & Holzer, and others, reiterated that a securities class action has been filed against Phreesia and that investors who bought shares between May 8, 2025 and March 30, 2026 may seek lead-plaintiff status before the July 13 deadline. Article Title
• Negative Sentiment: Additional law-firm notices alleged Phreesia may have made false or misleading statements about the sustainability of growth in its Network Solutions segment and its revenue outlook, reinforcing concerns that the lawsuit centers on guidance credibility and long-term growth assumptions. Article Title
• Negative Sentiment: Insider selling also added a modestly bearish signal, as Phreesia insider Yvonne Hui sold 1,371 shares under a pre-arranged trading plan, which can still be viewed unfavorably by investors during a period of legal uncertainty. Article Title

Institutional Investors Weigh In On Phreesia

Large investors have recently added to or reduced their stakes in the stock. Pale Fire Capital SE bought a new position in shares of Phreesia in the first quarter valued at approximately $72,481,000. Vanguard Group Inc. grew its stake in Phreesia by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 5,744,326 shares of the company’s stock valued at $97,194,000 after buying an additional 39,540 shares during the last quarter. Greenhouse Funds LLLP raised its holdings in Phreesia by 16.8% in the 3rd quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock worth $91,317,000 after acquiring an additional 557,265 shares during the period. Granahan Investment Management LLC raised its holdings in Phreesia by 73.8% in the 4th quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock worth $40,601,000 after acquiring an additional 1,018,987 shares during the period. Finally, Franklin Resources Inc. lifted its position in Phreesia by 28.8% during the 4th quarter. Franklin Resources Inc. now owns 2,000,082 shares of the company’s stock worth $33,841,000 after acquiring an additional 446,890 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Wall Street Analysts Forecast Growth

PHR has been the topic of a number of research reports. Stephens dropped their price objective on Phreesia from $32.00 to $20.00 and set an “overweight” rating on the stock in a report on Tuesday, March 31st. Robert W. Baird reissued a “neutral” rating and issued a $10.00 target price (down from $25.00) on shares of Phreesia in a research report on Tuesday, March 31st. Canaccord Genuity Group dropped their price target on shares of Phreesia from $22.00 to $16.00 and set a “buy” rating on the stock in a research note on Thursday, May 28th. Mizuho cut their price target on shares of Phreesia from $22.00 to $19.00 and set an “outperform” rating on the stock in a report on Tuesday, March 24th. Finally, Piper Sandler lowered shares of Phreesia from an “overweight” rating to a “neutral” rating and set a $12.00 price objective for the company. in a research note on Thursday, May 28th. Nine analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Phreesia has a consensus rating of “Hold” and a consensus price target of $16.65.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.